Report Overview
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The global Clinical Oncology Next Generation Sequencing (NGS) market size was estimated at USD 704.70 million in 2023 and is projected to reach USD 1745.02 million by 2032, exhibiting a CAGR of 10.60% during the forecast period.
North America Clinical Oncology Next Generation Sequencing (NGS) market size was estimated at USD 218.51 million in 2023, at a CAGR of 9.09% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Clinical Oncology Next Generation Sequencing (NGS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Clinical Oncology Next Generation Sequencing (NGS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Clinical Oncology Next Generation Sequencing (NGS) market in any manner.
Global Clinical Oncology Next Generation Sequencing (NGS) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Illumina
Roche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
Market Segmentation (by Type)
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Market Segmentation (by Application)
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Clinical Oncology Next Generation Sequencing (NGS) Market
Overview of the regional outlook of the Clinical Oncology Next Generation Sequencing (NGS) Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Clinical Oncology Next Generation Sequencing (NGS) Market Overview
2.1 Global Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Landscape
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Manufacturers (2019-2025)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2019-2025)
3.3 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Clinical Oncology Next Generation Sequencing (NGS) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Sales Sites, Area Served, Product Type
3.6 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.6.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Clinical Oncology Next Generation Sequencing (NGS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Clinical Oncology Next Generation Sequencing (NGS) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Clinical Oncology Next Generation Sequencing (NGS) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2025)
6.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2025)
6.4 Global Clinical Oncology Next Generation Sequencing (NGS) Price by Type (2019-2025)
7 Clinical Oncology Next Generation Sequencing (NGS) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Sales by Application (2019-2025)
7.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Application (2019-2025)
7.4 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2025)
8 Clinical Oncology Next Generation Sequencing (NGS) Market Consumption by Region
8.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 North America
8.2.1 North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Clinical Oncology Next Generation Sequencing (NGS) Market Production by Region
9.1 Global Production of Clinical Oncology Next Generation Sequencing (NGS) by Region (2019-2025)
9.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Region (2019-2025)
9.3 Global Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Clinical Oncology Next Generation Sequencing (NGS) Production
9.4.1 North America Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.4.2 North America Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Clinical Oncology Next Generation Sequencing (NGS) Production
9.5.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.5.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Clinical Oncology Next Generation Sequencing (NGS) Production (2019-2025)
9.6.1 Japan Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.6.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Clinical Oncology Next Generation Sequencing (NGS) Production (2019-2025)
9.7.1 China Clinical Oncology Next Generation Sequencing (NGS) Production Growth Rate (2019-2025)
9.7.2 China Clinical Oncology Next Generation Sequencing (NGS) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Illumina
10.1.1 Illumina Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Roche
10.2.1 Roche Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Agilent Technologies
10.3.1 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.3.4 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
10.3.5 Agilent Technologies Business Overview
10.3.6 Agilent Technologies Recent Developments
10.4 Knome
10.4.1 Knome Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.4.4 Knome Business Overview
10.4.5 Knome Recent Developments
10.5 Genomatix Software
10.5.1 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.5.4 Genomatix Software Business Overview
10.5.5 Genomatix Software Recent Developments
10.6 GATC Biotech
10.6.1 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.6.4 GATC Biotech Business Overview
10.6.5 GATC Biotech Recent Developments
10.7 Oxford Nanopore Technologies
10.7.1 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.7.4 Oxford Nanopore Technologies Business Overview
10.7.5 Oxford Nanopore Technologies Recent Developments
10.8 Macrogen
10.8.1 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.8.4 Macrogen Business Overview
10.8.5 Macrogen Recent Developments
10.9 Life Technologies
10.9.1 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.9.4 Life Technologies Business Overview
10.9.5 Life Technologies Recent Developments
10.10 DNASTAR
10.10.1 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.10.4 DNASTAR Business Overview
10.10.5 DNASTAR Recent Developments
10.11 Exosome Diagnostics
10.11.1 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.11.4 Exosome Diagnostics Business Overview
10.11.5 Exosome Diagnostics Recent Developments
10.12 Biomatters
10.12.1 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.12.4 Biomatters Business Overview
10.12.5 Biomatters Recent Developments
10.13 CLC Bio
10.13.1 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.13.4 CLC Bio Business Overview
10.13.5 CLC Bio Recent Developments
10.14 BGI
10.14.1 BGI Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.14.4 BGI Business Overview
10.14.5 BGI Recent Developments
10.15 Qiagen
10.15.1 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.15.4 Qiagen Business Overview
10.15.5 Qiagen Recent Developments
10.16 Perkin Elmer
10.16.1 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.16.4 Perkin Elmer Business Overview
10.16.5 Perkin Elmer Recent Developments
10.17 Pacific Bioscience
10.17.1 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.17.4 Pacific Bioscience Business Overview
10.17.5 Pacific Bioscience Recent Developments
10.18 Partek
10.18.1 Partek Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.18.4 Partek Business Overview
10.18.5 Partek Recent Developments
10.19 GnuBIO
10.19.1 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.19.4 GnuBIO Business Overview
10.19.5 GnuBIO Recent Developments
10.20 Foundation Medicine
10.20.1 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.20.4 Foundation Medicine Business Overview
10.20.5 Foundation Medicine Recent Developments
10.21 Paradigm
10.21.1 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.21.4 Paradigm Business Overview
10.21.5 Paradigm Recent Developments
10.22 Caris Life Sciences
10.22.1 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.22.4 Caris Life Sciences Business Overview
10.22.5 Caris Life Sciences Recent Developments
10.23 Myriad Genetics
10.23.1 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
10.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
10.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
10.23.4 Myriad Genetics Business Overview
10.23.5 Myriad Genetics Recent Developments
11 Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast
11.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.3 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region
11.2.4 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Clinical Oncology Next Generation Sequencing (NGS) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2032)
12.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2032)
12.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2025-2032)
12.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
12.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Clinical Oncology Next Generation Sequencing (NGS) Market Size Comparison by Region (M USD)
Table 5. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2022)
Table 10. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Sales Sites and Area Served
Table 12. Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Product Type
Table 13. Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Clinical Oncology Next Generation Sequencing (NGS)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
Table 22. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Type (K Units)
Table 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 24. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Type (2019-2025)
Table 25. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2025)
Table 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Type (2019-2025)
Table 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Type (2019-2025)
Table 28. Global Clinical Oncology Next Generation Sequencing (NGS) Price (USD/Unit) by Type (2019-2025)
Table 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Application
Table 30. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
Table 31. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2019-2025) & (K Units)
Table 32. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2025)
Table 33. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2019-2025) & (M USD)
Table 34. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2019-2025)
Table 35. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2025)
Table 36. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2025) & (K Units)
Table 37. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2025)
Table 38. North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2025) & (K Units)
Table 39. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2025) & (K Units)
Table 41. South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2025) & (K Units)
Table 43. Global Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) by Region (2019-2025)
Table 44. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Region (2019-2025)
Table 46. Global Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Clinical Oncology Next Generation Sequencing (NGS) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Illumina Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 52. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 53. Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Illumina Business Overview
Table 55. Illumina Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 56. Illumina Recent Developments
Table 57. Roche Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 58. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 59. Roche Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Roche Business Overview
Table 61. Roche Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 62. Roche Recent Developments
Table 63. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 64. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 65. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 67. Agilent Technologies Business Overview
Table 68. Agilent Technologies Recent Developments
Table 69. Knome Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 70. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 71. Knome Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Knome Business Overview
Table 73. Knome Recent Developments
Table 74. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 75. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 76. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Genomatix Software Business Overview
Table 78. Genomatix Software Recent Developments
Table 79. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 80. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 81. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. GATC Biotech Business Overview
Table 83. GATC Biotech Recent Developments
Table 84. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 85. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 86. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Oxford Nanopore Technologies Business Overview
Table 88. Oxford Nanopore Technologies Recent Developments
Table 89. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 90. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 91. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Macrogen Business Overview
Table 93. Macrogen Recent Developments
Table 94. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 95. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 96. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Life Technologies Business Overview
Table 98. Life Technologies Recent Developments
Table 99. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 100. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 101. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. DNASTAR Business Overview
Table 103. DNASTAR Recent Developments
Table 104. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 105. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 106. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Exosome Diagnostics Business Overview
Table 108. Exosome Diagnostics Recent Developments
Table 109. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 110. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 111. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Biomatters Business Overview
Table 113. Biomatters Recent Developments
Table 114. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 115. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 116. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. CLC Bio Business Overview
Table 118. CLC Bio Recent Developments
Table 119. BGI Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 120. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 121. BGI Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. BGI Business Overview
Table 123. BGI Recent Developments
Table 124. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 125. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 126. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Qiagen Business Overview
Table 128. Qiagen Recent Developments
Table 129. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 130. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 131. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Perkin Elmer Business Overview
Table 133. Perkin Elmer Recent Developments
Table 134. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 135. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 136. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 137. Pacific Bioscience Business Overview
Table 138. Pacific Bioscience Recent Developments
Table 139. Partek Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 140. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 141. Partek Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 142. Partek Business Overview
Table 143. Partek Recent Developments
Table 144. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 145. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 146. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 147. GnuBIO Business Overview
Table 148. GnuBIO Recent Developments
Table 149. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 150. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 151. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 152. Foundation Medicine Business Overview
Table 153. Foundation Medicine Recent Developments
Table 154. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 155. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 156. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 157. Paradigm Business Overview
Table 158. Paradigm Recent Developments
Table 159. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 160. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 161. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 162. Caris Life Sciences Business Overview
Table 163. Caris Life Sciences Recent Developments
Table 164. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 165. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 166. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 167. Myriad Genetics Business Overview
Table 168. Myriad Genetics Recent Developments
Table 169. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2032) & (K Units)
Table 170. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2032) & (M USD)
Table 171. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2032) & (K Units)
Table 172. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2032) & (M USD)
Table 173. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2032) & (K Units)
Table 174. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2032) & (M USD)
Table 175. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2032) & (K Units)
Table 176. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2032) & (M USD)
Table 177. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2032) & (K Units)
Table 178. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2032) & (M USD)
Table 179. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast by Country (2025-2032) & (Units)
Table 180. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2032) & (M USD)
Table 181. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Type (2025-2032) & (K Units)
Table 182. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2032) & (M USD)
Table 183. Global Clinical Oncology Next Generation Sequencing (NGS) Price Forecast by Type (2025-2032) & (USD/Unit)
Table 184. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application (2025-2032)
Table 185. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Clinical Oncology Next Generation Sequencing (NGS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD), 2019-2032
Figure 5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) (2019-2032)
Figure 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (M USD)
Figure 11. Clinical Oncology Next Generation Sequencing (NGS) Sales Share by Manufacturers in 2023
Figure 12. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers in 2023
Figure 13. Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type
Figure 18. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2019-2025)
Figure 19. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2023
Figure 20. Market Size Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2019-2025)
Figure 21. Market Size Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application
Figure 24. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2025)
Figure 25. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application in 2023
Figure 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2019-2025)
Figure 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2023
Figure 28. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2025)
Figure 30. North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 32. U.S. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 37. Germany Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 44. China Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 50. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 51. Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Clinical Oncology Next Generation Sequencing (NGS) Production Market Share by Region (2019-2025)
Figure 62. North America Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2019-2025)
Figure 65. China Clinical Oncology Next Generation Sequencing (NGS) Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Type (2025-2032)
Figure 70. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Application (2025-2032)
Figure 71. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Application (2025-2032)
